Subsets of natural killer cells in chronic myeloid leukemia and their relation with some inflammatory cytokines

Subsets of natural killer cells in chronic myeloid leukemia and their relation with some inflammatory cytokines

BACKGROUND: As in other malignancies, different subsets of natural killer (NK) cells play a crucial role in the recognition and lysing of malignant cells in chronic myeloid leukemia (CML). OBJECTIVES: This study aims to identify two subsets of NK, cytotoxic (cluster of differentiation [CD] 16+bright...

Full description

Bibliographic Details
Main Authors:	Yusur Falah Faraj, Khalid Mahdi Salih, Abderrahim Khelif, Elaf Zuhair Hameed
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Iraqi Journal of Hematology
Subjects:	chronic myeloid leukemia cluster of differentiation 16+ cluster of differentiation 56+ interferon-gamma interleukin-18 natural killer
Online Access:	http://www.ijhonline.org/article.asp?issn=2072-8069;year=2023;volume=12;issue=2;spage=184;epage=189;aulast=Faraj

Similar Items

Immunophenotyping of normal individuals classified on the basis of human dosha prakriti
by: Harish Rotti, et al.
Published: (2014-01-01)

Molecular mechanisms of differentiation of murine pro-inflammatory gamma-delta T cell subsets
by: Bruno eSilva-Santos, et al.
Published: (2013-12-01)

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
by: Yeon Ho Choi, et al.
Published: (2019-07-01)

Neural cell adhesion molecule (cluster of differentiation 56) in health and disease
by: Syed Z. A Zaidi, et al.
Published: (2015-01-01)

Phenotypic Study of Natural Killer Cell Subsets in Ankylosing Spondylitis Patients
by: Tahereh Mousavi, et al.
Published: (2009-12-01)

Vitiligo: Correlation with cytokine profiles and its role in novel therapeutic strategies: A case–control study
by: Karishma Desai, et al.
Published: (2023-01-01)

T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
by: Hammad R, et al.
Published: (2021-04-01)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
by: Takahiro Uchida, et al.
Published: (2022-01-01)

Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset
by: Mathieu Amand, et al.
Published: (2017-06-01)

Interleukin-15 as a potential regulator of the innate immune response
by: W. Carson, et al.
Published: (1998-01-01)

The Frequency of Natural Killer Cell Subsets in Patients with Acquired Immune Deficiency Syndrome with Deep Fungal Infections
by: Chen G, et al.
Published: (2021-02-01)

Diagnostic Utility of Immunohistochemistry Markers Galectin-3, CK19 and CD56 in Thyroid Neoplasms: A Descriptive Study
by: Jayasree Raman, et al.
Published: (2022-12-01)

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients
by: Beatriz Sanchez-Correa, et al.
Published: (2017-08-01)

Early T-Cell Precursor Acute Lymphoblastic Leukaemia/Lymphoma: Immunohistochemical Evaluation of Four Lymph Node Biopsies
by: Divya Shelly, et al.
Published: (2017-07-01)

Role of Natural Killer T Cells in the Development of Obesity and Insulin Resistance: Insights From Recent Progress
by: Masashi Satoh, et al.
Published: (2018-06-01)

Interferon therapy shifts natural killer subsets among egyptian patients with chronic hepatitis C
by: Amal Fathy, et al.

Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development
by: Mohamed F. Mandour, et al.
Published: (2020-05-01)

Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
by: Nidhal Abdul-Muhaimen, et al.
Published: (2019-11-01)

Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
by: Nidhal Abdul-Muhaimen, et al.
Published: (2019-11-01)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
by: Silvia Gaggero, et al.
Published: (2021-01-01)

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
by: Anne-Sophie Chretien, et al.
Published: (2017-05-01)

Suppression of Natural Killer Cell Activity by Regulatory NKT10 Cells Aggravates Alcoholic Hepatosteatosis
by: Kele Cui, et al.
Published: (2017-10-01)

Cytokines profiling as prognostic markers in newly diagnosed acute myeloid leukemia
by: Hiba Shakir Ahmed, et al.
Published: (2017-01-01)

Th-1 and Th-2 cytokine production in infants with virus-associated wheezing
by: P.M.C. Pitrez, et al.
Published: (2005-01-01)

Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns
by: Xiao-Jun Xu, et al.
Published: (2022-02-01)

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
by: Ana Paula Alegretti, et al.
Published: (2011-06-01)

Cytokine profiling for Egyptian diabetic patients with nephropathy
by: Samar M Samir, et al.
Published: (2022-01-01)

In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation
by: Yoojin Lee, et al.
Published: (2020-09-01)

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
by: Cristina Zalfa, et al.
Published: (2021-05-01)

Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission
by: Pierre‐Yves Dumas, et al.
Published: (2019-09-01)

5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts
by: Vilma Dembitz, et al.
Published: (2020-11-01)

Beneficial immunostimulatory effect of short-term <it>Chlorella</it> supplementation: enhancement of <it>Natural Killer</it> cell activity and early inflammatory response (Randomized, double-blinded, placebo-controlled trial)
by: Kwak Jung, et al.
Published: (2012-07-01)

Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling
by: Jessica C. Kling, et al.
Published: (2018-03-01)

Recent Progress in Interferon Therapy for Myeloid Malignancies
by: Fiona M. Healy, et al.
Published: (2021-10-01)

The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome
by: Annette K. Brenner, et al.
Published: (2019-01-01)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
by: Sarah Parisi, et al.
Published: (2017-10-01)

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
by: Kerry Dobbs, et al.
Published: (2017-07-01)

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
by: Kerry Dobbs, et al.
Published: (2017-10-01)

Interleukin-1α Mediates Ozone-Induced Myeloid Differentiation Factor-88-Dependent Epithelial Tissue Injury and Inflammation
by: Chloé Michaudel, et al.
Published: (2018-05-01)

CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
by: Lazar Vujanovic, et al.
Published: (2019-01-01)